节点文献
新型冠状病毒肺炎相关肝损伤研究进展
Research advances in coronavirus disease 2019-related liver injury
【摘要】 新型冠状病毒肺炎的大流行对全球的公共卫生安全造成了巨大威胁及挑战,并改变了医疗配置的优先性。在新型冠状病毒肺炎的临床诊治中,可以观察到相当比例的患者发生肝损伤,尤其是重症或危重症患者。本文总结新型冠状病毒肺炎致肝损伤的流行病学、机制、临床特征及治疗,希望可对临床医生的决策和优化治疗提供帮助。
【Abstract】 The coronavirus disease 2019(COVID-19) pandemic has brought great threats and challenges to global public health and has changed the priorities of medical resource allocation. A considerable proportion of patients with liver injury is observed during the clinical diagnosis and treatment of COVID-19, especially in those with a severe or critical illness. This article summarizes the epidemiology, mechanism, clinical features, and treatment of liver injury caused by COVID-19, in order to help clinicians with decision making and treatment optimization.
【关键词】 新型冠状病毒肺炎;
肝功能不全;
药物性肝损伤;
治疗学;
【Key words】 Coronavirus Disease 2019; Hepatic Insufficiency; Drug Induced Liver Injury; Therapeutics;
【Key words】 Coronavirus Disease 2019; Hepatic Insufficiency; Drug Induced Liver Injury; Therapeutics;
【基金】 天津科技重大专项与工程重大疾病防治(19ZXDBSY00030)~~
- 【文献出处】 临床肝胆病杂志 ,Journal of Clinical Hepatology , 编辑部邮箱 ,2022年04期
- 【分类号】R563.1;R575
- 【被引频次】1
- 【下载频次】465